Cited by 322Psychedelics and Drug StudiesAlkaloids: synthesis and pharmacologySynthesis and bioactivity of alkaloids

The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

McKenna, Dennis J·2004·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2004.03.002

Open this paper in CoChat — free account

Abstract

Ayahuasca is a hallucinogenic beverage that is prominent in the ethnomedicine and shamanism of indigenous Amazonian tribes. Its unique pharmacology depends on the oral activity of the hallucinogen, N,N-dimethyltryptamine (DMT), which results from inhibition of monoamine oxidase (MAO) by beta-carboline alkaloids. MAO is the enzyme that normally degrades DMT in the liver and gut. Ayahuasca has long been integrated into mestizo folk medicine in the northwest Amazon. In Brazil, it is used as a sacrament by several syncretic churches. Some of these organizations have incorporated in the United States. The recreational and religious use of ayahuasca in the United States, as well as "ayahuasca tourism" in the Amazon, is increasing. The current legal status of ayahuasca or its source plants in the United States is unclear, although DMT is a Schedule I controlled substance. One ayahuasca church has received favorable rulings in 2 federal courts in response to its petition to the Department of Justice for the right to use ayahuasca under the Religious Freedom Restoration Act. A biomedical study of one of the churches, the Uñiao do Vegetal (UDV), indicated that ayahuasca may have therapeutic applications for the treatment of alcoholism, substance abuse, and possibly other disorders. Clinical studies conducted in Spain have demonstrated that ayahuasca can be used safely in normal healthy adults, but have done little to clarify its potential therapeutic uses. Because of ayahuasca's ill-defined legal status and variable botanical and chemical composition, clinical investigations in the United States, ideally under an approved Investigational New Drug (IND) protocol, are complicated by both regulatory and methodological issues. This article provides an overview of ayahuasca and discusses some of the challenges that must be overcome before it can be clinically investigated in the United States.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2004.03.002

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
Serotonergic Studies in Patients With Affective and Personality Disorders
Coccaro, E. F. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070013002 · Cited by 1,085
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Evidence of linkage between the serotonin transporter and autistic disorder
Cook, E., Yeung-Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A. J., Haas, R., Courchesne, E., & LEVENTHAL, B. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000266 · Cited by 426
Hallucinogens and shamanism
Harner, M. J. (1973) · Oxford University Press eBooks · Cited by 406
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398
Self-citation
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
The Human Platelet
Stahl, S. M. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770170019001 · Cited by 386
Amazonia 1492: Pristine Forest or Cultural Parkland?
Heckenberger, M. J., Kuikuro, A., Kuikuro, U. T., Russell, J. C., Schmidt, M., Fausto, C., & Franchetto, B. (2003) · Science · doi:10.1126/science.1086112 · Cited by 384

Flagged first, then by citations

Show all 103 references

1 of the 103 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

Airaksinen, 1981, β-Carbolines, psychoactive compounds in the mammalian body, Med Biol, 59, 21
Anonymous, 1855, Journal of a voyage up the Amazon and Rio Negro by Richard Spruce, San Carlos del Rio Negro, June 27, 1853, Hooker J Bot Kew Garden Misc, 6/7
Center for Cognitive Liberty and Ethics (2002a). Federal court rules in favor of ayahuasca-using church [Press release]. Available at: http://www.cognitiveliberty.org/dll/udv_pj_granted.htm.
Ho, 1979, Pharmacological and biochemical studies with β-carboline analogs, vol. 4, 215
Krajick, 1992, Vision quest, Newsweek, 44
Naranjo, 1986, El ayahuasca in la arqueologı́a ecuatoriana, Am Indig, 46, 117
Schultes, 1972, Ethnotoxocological significance of additives to New World hallucinogens, Plant Sci Bull, 18, 34
Topping, 1998, Ayahuasca and cancer: one man's experience, Bull Multidiscip Assoc Psychedelic Stud, 8, 22
Winkelman, 1995, Psychointegrator plants: their roles in human consciousness, cultures, and health, Yearb Cross-Cult Med Psychother, 9

Sorted by citations

Items 101–200 of 322

Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential
Santos, B. W. L., de Oliveira, R. C., Sonsin‐Oliveira, J., Fagg, C. W., Barbosa, J. B. F., & Caldas, E. D. (2020) · Plants · doi:10.3390/plants9070870 · Cited by 35
Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks
Gaujac, A., Martinez, S. T., Gomes, A. A., de Andrade, S. J., Pinto, Â. D. C., David, J. M., Navickiene, S., & de Andrade, J. B. (2012) · Microchemical Journal · doi:10.1016/j.microc.2012.03.033 · Cited by 36
Analytical techniques for the determination of tryptamines and β‐carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo‐shamanic urban practices
Gaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & de Andrade, J. B. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1343 · Cited by 40
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33
A Brief Historical Overview of Psychedelic Research
Geyer, M. A. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.11.003 · Cited by 39
Determination of Dimethyltryptamine And β-Carbolines (Ayahuasca Alkaloids) in Plasma Samples By Lc–MS/MS
de Oliveira, C. D. R., Okai, G. G., Costa, J. L., de Almeida, R. M., Oliveira‐Silva, D., & Yonamine, M. (2012) · Bioanalysis · doi:10.4155/bio.12.124 · Cited by 33
Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures
Lesiak, A. D., & Musah, R. A. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.06.009 · Cited by 33
Spirituality, drugs, and tourism: tourists’ and shamans’ experiences of ayahuasca in Iquitos, Peru
Prayag, G., Mura, P., Hall, C. M., & Fontaine, J. (2016) · Tourism Recreation Research · doi:10.1080/02508281.2016.1192237 · Cited by 33
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
O’Shaughnessy, D. M., Berlowitz, I., Rodd, R., Sarnyai, Z., & Quirk, F. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320986634 · Cited by 32
Phytotherapy of Alcoholism
Tomczyk, M., Končić, M. Z., & Chrostek, L. (2012) · Natural Product Communications · doi:10.1177/1934578x1200700243 · Cited by 32
Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life
Kaasik, H., & Kreegipuu, K. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1748773 · Cited by 37
qNMR: An applicable method for the determination of dimethyltryptamine in ayahuasca, a psychoactive plant preparation
Moura, S., Carvalho, F. G., de Oliveira, C. D. R., Pinto, E., & Yonamine, M. (2010) · Phytochemistry Letters · doi:10.1016/j.phytol.2009.12.004 · Cited by 30
A ayahuasca e o tratamento da dependência
Mercante, M. S. (2013) · Mana · doi:10.1590/s0104-93132013000300005 · Cited by 30
Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice
Shen, H.-W., Jiang, X.-L., & Yu, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039107 · Cited by 29
Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status
Jiang, X.-L., Shen, H.-W., Mager, D. E., & Yu, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050724 · Cited by 29
Analytical chemistry of synthetic routes to psychoactive tryptamines : Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS
Brandt, S. D., Freeman, S., Fleet, I. A., McGagh, P., & Alder, J. F. (2004) · The Analyst · doi:10.1039/b407239c · Cited by 29
Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Serra, Y. A., Barros-Santos, T., Anjos-Santos, A., Kisaki, N. D., Jovita-Farias, C., Leite, J. P., Santana, M. C. E., Coimbra, J. P. S. A., de Jesus, N. M. S., Sulima, A., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06104-w · Cited by 27
Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry
Anderson, B. T. (2012) · Anthropology of Consciousness · doi:10.1111/j.1556-3537.2012.01056.x · Cited by 30
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B., & Lee, K. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.01.039 · Cited by 34
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 33
Ayahuasca Beverages: Phytochemical Analysis and Biological Properties
Gonçalves, J., Luís, Â., Gradillas, A., Garcı́a, A., Restolho, J., Fernández, N., Domingues, F., Gallardo, E., & Duarte, A. P. (2020) · Antibiotics · doi:10.3390/antibiotics9110731 · Cited by 29
Photophysical and Photochemical Properties of Naturally Occurring normelinonine F and Melinonine F Alkaloids and Structurally Related N(2)‐ and/or N(9)‐methyl‐β‐carboline Derivatives
Rasse‐Suriani, F. A. O., Einschlag, F. S. G., Rafti, M., León, T. S. D., Gara, P. M. D., Erra‐Balsells, R., & Cabrerizo, F. M. (2017) · Photochemistry and Photobiology · doi:10.1111/php.12811 · Cited by 27
Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors
Jiang, X.-L., Shen, H.-W., & Yu, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.013 · Cited by 26
Development of a LC–MS/MS Method to Analyze 5-Methoxy-N,N-Dimethyltryptamine and Bufotenine: Application to Pharmacokinetic Study
Shen, H.-W., Jiang, X.-L., & Yu, A. (2009) · Bioanalysis · doi:10.4155/bio.09.7 · Cited by 26
Treating Addiction
Tófoli, L. F., & de Araújo, D. B. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.005 · Cited by 35
Neurobehavioral, reflexological and physical development of Wistar rat offspring exposed to ayahuasca during pregnancy and lactation
de Oliveira, C. D. R., Moreira, C. Q., Spinosa, H. D. S., & Yonamine, M. (2011) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2011005000170 · Cited by 26
Profiling psychoactive tryptamine-drug synthesis by focusing on detection using mass spectrometry
Martins, C. P. B., Freeman, S., Alder, J. F., Passie, T., & Brandt, S. D. (2010) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2010.01.009 · Cited by 25
Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity
Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114865 · Cited by 25
The Importance of Ritual Discourse in Framing Ayahuasca Experiences in the Context of Shamanic Tourism
Fotiou, E. (2020) · Anthropology of Consciousness · doi:10.1111/anoc.12117 · Cited by 24
Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties
Politi, M., Tresca, G., Menghini, L., & Ferrante, C. (2021) · Planta Medica · doi:10.1055/a-1675-3840 · Cited by 25
Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Taylor, A. P., Mortari, M. R., & Caldas, E. D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00854-w · Cited by 23
Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases
da Silva, M. G., Daros, G. C., & de Bitencourt, R. M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113003 · Cited by 27
Fast determination of harmala alkaloids in edible algae by capillary electrophoresis mass spectrometry
Tascón, M., Benavente, F., Sanz‐Nebot, V., & Gagliardi, L. G. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8579-4 · Cited by 22
Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations
Reis, H. S., Rodrigues, I. R. S., Anjos-Santos, A., Libarino-Santos, M., Serra, Y. A., Cata-Preta, E. G., Oliveira-Campos, D., Kisaki, N. D., Barros-Santos, T., Yokoyama, T. S., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05609-6 · Cited by 21
DMT at fifty.
Szara, S. I. (2007) · PubMed · Cited by 22
Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure
Santos, A. D. F. A., Vieira, A. L. S., Pic‐Taylor, A., & Caldas, E. D. (2017) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2017.01.006 · Cited by 21
An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice
Correa-Netto, N. F., Masukawa, M. Y., Nishide, F., Galfano, G. S., Tamura, F., Shimizo, M. K., Marcato, M. P., Santos-Junior, J. G., & Linardi, A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176036 · Cited by 21
Ayahuasca and the traveller: A scoping review of risks and possible benefits
Houle, S. K. D., Evans, D., Carter, C. A., & Schlagenhauf, P. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102206 · Cited by 20
Parts-per-trillion detection of harmala alkaloids in Undaria pinnatifida algae by on-line solid phase extraction capillary electrophoresis mass spectrometry
Tascón, M., Gagliardi, L. G., & Benavente, F. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.12.012 · Cited by 20
Altered States During Shamanic Drumming: A Phenomenological Study
Kjellgren, A., & Eriksson, A. (2010) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2010.29.2.1 · Cited by 20
Reply to “Ayahuasca turned on my mind’s eye”: A case of acquired versus congenital aphantasia, as evidenced with DMT use?
Luke, D. P. (2018) · Journal of Psychedelic Studies · doi:10.1556/2054.2018.014 · Cited by 20
Reaction of N , N -Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions
Dunlap, L. E., & Olson, D. E. (2018) · ACS Omega · doi:10.1021/acsomega.8b00507 · Cited by 19
Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation
Schenberg, E. E., & Gerber, K. (2022) · Transcultural Psychiatry · doi:10.1177/13634615211062962 · Cited by 21
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Microwave‐accelerated synthesis of psychoactive deuterated N,N‐dialkylated‐[α,α,β,β‐d4]‐tryptamines
Brandt, S. D., Tirunarayanapuram, S. S., Freeman, S., Dempster, N. M., Barker, S. A., Daley, P. F., Cozzi, N. V., & Martins, C. P. B. (2008) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1557 · Cited by 19
A rapid and simple method for the determination of psychoactive alkaloids by CE‐UV: application to Peganum Harmala seed infusions
Tascón, M., Benavente, F., Vizioli, N. M., & Gagliardi, L. G. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1989 · Cited by 18
Ayahuasca Pretreatment Prevents Sepsis-Induced Anxiety-Like Behavior, Neuroinflammation, and Oxidative Stress, and Increases Brain-Derived Neurotrophic Factor
de Camargo, R. W., Joaquim, L. D. S., Machado, R. S., Ramos, S. D. S., da Rosa, L. R., Júnior, L. R. D. N., Mathias, K., Maximiano, L., Strickert, Y. R., Nord, R., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04597-4 · Cited by 18
Ayahuasca and Human Destiny
McKenna, D. J. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399805 · Cited by 17
Self-citation
Evaluating herbal medicine preparation from a traditional perspective: insights from an ethnopharmaceutical survey in the Peruvian Amazon
Tresca, G., Marcus, O., & Politi, M. (2020) · Anthropology and Medicine · doi:10.1080/13648470.2019.1669939 · Cited by 17
Tryptamines
Greene, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00015-8 · Cited by 20
Effects of Hallucinogens on Neuronal Activity
Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano‐Rodriguez, E., Santana, N., & Artigas, F. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_473 · Cited by 17
Analytical characterisation of the routes by thermolytic decarboxylation from tryptophan to tryptamine using ketone catalysts, resulting in tetrahydro-β-carboline formation
Brandt, S. D., Mansell, D. J., Freeman, S., Fleet, I. A., & Alder, J. F. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.02.007 · Cited by 17
Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 20
Indigenous-Amazonian Traditional Medicine’s Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study
Berlowitz, I., Torres, E. G., Maake, C., Wolf, U., & Martin-Söelch, C. (2023) · Plants · doi:10.3390/plants12020346 · Cited by 20
Banisteriopsis Species: A Source of Bioactive of Potential Medical Application
de Frias (2012) · International Journal of Biotechnology for Wellness Industries · doi:10.6000/1927-3037/2012.01.03.02 · Cited by 16
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Soares, B. L., Eduardo-da-Silva, P., Amarilha, H., Pinheiro‐da‐Silva, J., Silva, P. F., & Luchiari, A. C. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00190 · Cited by 17
Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS
Tavares, L. S., Monedeiro, F., Bordin, D. M., & Martinis, B. S. D. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz116 · Cited by 17
Moderators of ayahuasca’s biological antidepressant action
de Sousa, G. M., Tavares, V. D. D. O., Galvão, A. C. D. M., de Almeida, R. N., Palhano-Fontes, F., Soares, B. L., Freire, F. A. D. M., Nunes, E. A., Maia‐de‐Oliveira, J. P., Perkins, D., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1033816 · Cited by 17
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
Madrid-Gambín, F., Gomez‐Gómez, À., Busquets-García, A., Haro, N., Marco, S., Mason, N. L., Reckweg, J. T., Mallaroni, P., Kloft, L., van Oorsouw, K. I. M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112845 · Cited by 17
Alcaloides e o chá de ayahuasca: uma correlação dos "estados alterados da consciência" induzido por alucinógenos
de Souza, P. A. (2011) · Revista Brasileira de Plantas Medicinais · doi:10.1590/s1516-05722011000300015 · Cited by 21
Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users
Mello, S. M., Soubhia, P. C., Silveira, G. D. O., Correa-Netto, N. F., Lanaro, R., Costa, J. L., & Linardi, A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1557355 · Cited by 19
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
Vamvakopoulou, I. A., & Nutt, D. J. (2024) · European Addiction Research · doi:10.1159/000540062 · Cited by 18
Rock Art or Rorschach: Is there More to Entoptics than Meets the Eye?
Luke, D. P. (2010) · Time and Mind · doi:10.2752/175169710x12549020810371 · Cited by 14
SPE/RP-HPLC using C1 columns: an environmentally friendly alternative to conventional reverse-phase separations for quantitation of beta-carboline alkaloids in human serum samples
González‐Ruiz, V., Olives, A. I., & Martín, M. A. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4562-2 · Cited by 14
Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry
de Morais, D. R., Lanaro, R., Barbosa, I. L., Santos, J. M., da Cunha, K. F., Hernandes, V. V., Tessaro, E. P., Gomes, C. S., Eberlin, M. N., & Costa, J. L. (2017) · Forensic Toxicology · doi:10.1007/s11419-017-0394-5 · Cited by 14
Ayahuasca: uma revisão dos aspectos farmacológicos e toxicológicos
Pires, A. P. S., de Oliveira, C. D. R., & Yonamine, M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 14
New therapeutic potential for psychoactive natural products
Prevatt‐Smith, K. M., & Prisinzano, T. E. (2009) · Natural Product Reports · doi:10.1039/b912196j · Cited by 14
The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist
Dean, A. K. (2019) · Journal of Marketing Management · doi:10.1080/0267257x.2019.1601635 · Cited by 13
A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS
Eller, S., Borges, G. R., Ossanes, D. S., Birk, L., Scheid, C., Yonamine, M., Grossi, P., Merib, J. D. O., & de Oliveira, T. F. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110298 · Cited by 13
Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms
Jiang, X.-L., Shen, H.-W., & Yu, A.-M. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.01.008 · Cited by 13
Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects
Nižňanský, Ľ., Nižnanská, Ž., Kuruc, R., Szórádová, A., Šikuta, J., & Zummerová, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041147 · Cited by 13
LC–MS/MS Quantitative Determination of Tetrapterys mucronata Alkaloids, a Plant Occasionally used in Ayahuasca Preparation
Queiroz, M. M. F., Marti, G., Queiroz, E. F., Marcourt, L., Castro‐Gamboa, I., Bolzani, V. D. S., & Wolfender, J. (2015) · Phytochemical Analysis · doi:10.1002/pca.2548 · Cited by 12
Psychosis induced by abuse of ayahuasca: a case report
Palma-Álvarez, R. F., Grau‐López, L., Ros‐Cucurull, E., Abad, A. C., Dualde, J., Robles-Martínez, M., & Roncero, C. (2020) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2019.10.005 · Cited by 12
Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine
Silveira, G. D. O., Lourenço, F. R., Bruno, V., & Yonamine, M. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.558501 · Cited by 14
The Therapeutic Potential of Ayahuasca
Coe, M. A., & McKenna, D. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-42307-4_7 · Cited by 12
Self-citation
Characterisation of a proposed internet synthesis of N,N-dimethyltryptamine using liquid chromatography/electrospray ionisation tandem mass spectrometry
Martins, C. P. B., Freeman, S., Alder, J. F., & Brandt, S. D. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.06.060 · Cited by 11
NPC Natural Product Communications
Khana, S. I., Hester, J. P., Tekwania, B. L., Midiwob, J. O., Muhammada, I., Jaina, S. K., Jacoba, M. R., Walkera, L. A., Rahmana, A. A., & Samoylenkoa, V. (2011) · Cited by 11
Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease
Neto, A. K., Santos, M. F. C., Boas, D. F. V., Gonçalves-Santos, E., Veloso, M. P., Bueno, P. C. P., Caldas, I. S., Soares, M. G., Dias, D. F., & Chagas‐Paula, D. A. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200409 · Cited by 10
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
Weleff, J., Nunes, J. C., Costa, G. P. A., Sofuoglu, M., MacLean, R. R., & Aquino, J. P. D. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16045 · Cited by 12
An Account of Healing Depression UsingAyahuascaPlant Teacher Medicine in a Santo Daime Ritual
Sobiecki, J.-F. (2013) · Indo-Pacific Journal of Phenomenology · doi:10.2989/ipjp.2013.13.1.7.1173 · Cited by 10
A High By Any Other Name: Exploring the Motivations for Consumption of “Legal Highs”
Wiecko, F. M., Thompson, W. E., & Parham, B. P. (2016) · Deviant Behavior · doi:10.1080/01639625.2016.1197034 · Cited by 10
Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol
Pires, J. M., Mendes, F. R., Pires, A. P. S., Yonamine, M., do Amaral, J. L. G., & Carlini, E. A. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000117174 · Cited by 10
N -Methyl-β-carboline alkaloids: structure-dependent photosensitizing properties and localization in subcellular domains
Denofrio, M. P., Rasse‐Suriani, F. A. O., Paredes, J. M., Fassetta, F., Crovetto, L., Girón, M. D., Salto, R., Epe, B., & Cabrerizo, F. M. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01122c · Cited by 10
Herbal Anxiolytics: Sources and Their Preparation Methods
Allameh, M., & Orsat, V. (2022) · Food Reviews International · doi:10.1080/87559129.2022.2043895 · Cited by 11
Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry
Gaujac, A., Ford, J. L., Dempster, N. M., de Andrade, J. B., & Brandt, S. D. (2013) · Microchemical Journal · doi:10.1016/j.microc.2013.03.009 · Cited by 10
Can Ayahuasca and sleep loss change sexual performance in male rats?
Alvarenga, T. A., Polesel, D. N., Matos, G., Garcia, V. A., Costa, J. L., Tufik, S., & Andersen, M. L. (2014) · Behavioural Processes · doi:10.1016/j.beproc.2014.09.024 · Cited by 10
The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Ingegneri, M., Smeriglio, E., Zebbiche, Y., Cornara, L., Visalli, L., Smeriglio, A., & Trombetta, D. (2025) · Toxics · doi:10.3390/toxics13040247 · Cited by 9
Ayahuasca Treatment Center Safety for the Western Seeker
Ray, R. R., & Lassiter, K. S. (2016) · Anthropology of Consciousness · doi:10.1111/anoc.12060 · Cited by 9
Determination of the Elemental Composition of Ayahuasca and Assessments Concerning Consumer Safety
Guimarães, I. C., Tófoli, L. F., & Sussulini, A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02226-4 · Cited by 9
Vegetative anatomy, morphology and histochemistry of three species of Malpighiaceae used in analogues of the Amazonian psychoactive beverage Ayahuasca
Nagamine-Pinheiro, N., Fagg, C. W., Gomes, S. M., de Oliveira, R. C., & Sonsin‐Oliveira, J. (2020) · Flora · doi:10.1016/j.flora.2020.151760 · Cited by 9
Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu
Kavenská, V., & Šimonová, H. (2014) · Anthropologia integra · doi:10.5817/ai2014-1-51 · Cited by 9
Ayahuasca, entheogenic education & public policy
Tupper, K. W. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0064622 · Cited by 9
Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy
Mu, H., Ye, L., & Wang, B. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116361 · Cited by 8
Ayahuasca: entre o legal e o cultural
Garrido, R. G., & Sabino, B. D. (2009) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v14i2p44-53 · Cited by 9
Mapping Psilocybin-Assisted Therapies: A Scoping ReviewPreprint
Shore, R., Ioudovski, P., Goldie, C. E., McKeown, S., & Dumont, É. C. (2019) · medRxiv · doi:10.1101/2019.12.04.19013896 · Cited by 8
Therapeutic Use of Hallucinogens
Wiltenburg, V. D., Prado, D. D. R., & Mendes, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_35 · Cited by 1
AYAHUASCA: neuroquímica e farmacologia
SANTOS, R. G. D. (2007) · SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português) · doi:10.11606/issn.1806-6976.v3i1p01-11 · Cited by 9
Developing Treatments for Stimulant Abuse: A Brief Overview.
Davidson, C. (2016) · PubMed · Cited by 7
Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos
Timmermann, C. (2014) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272014000200005 · Cited by 10
Ayahuasca, dependência química e alcoolismo
Mercante, M. S. (2009) · Ponto Urbe · doi:10.4000/pontourbe.1345 · Cited by 7

Authors: McKenna, D. J.
Affiliations: University of Minnesota (US)
Corresponding author: McKenna, Dennis J
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2004-05
Volume: 102
Issue: 2
Pages: 111-129
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2004.03.002
OpenAlex: W2161026846
Cited by: 321
References: 103
Citations by year: 2026: 7 · 2025: 11 · 2024: 16 · 2023: 9 · 2022: 23 · 2021: 17 · 2020: 33 · 2019: 12 · 2018: 22 · 2017: 15 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 12 · 2012: 20
FWCI: 0.85
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
Keywords: ayahuasca, N,N-dimethyltryptamine, monoamine oxidase inhibition, β-carbolines, ayahuasca tourism, Religious Freedom Restoration Act, União do Vegetal, alcoholism treatment, addiction treatment, clinical research regulation, Schedule I controlled substances, hallucinogens
MeSH terms: Brazil, Clinical Trials as Topic, N,N-Dimethyltryptamine, Humans, Legislation, Drug, Phytotherapy, Plant Extracts, Psychotropic Drugs, United States, United States Food and Drug Administration, Molecular Structure, Banisteriopsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks